Attovia Therapeutics Inc ATTO

US Biotechnology

$16.10 ▲ +0.88% (+$0.14)

Open $15.56

Prev Close $15.96

Day Range $14.10 – $16.93

52W Range $12.94 – $28.00

Market Cap $728.59M

Beta 16,577.20

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
IPO Date	2026-08-05
Shares Out.	45,650,000
Website	attovia.com ↗
Phone	13025310855

About Attovia Therapeutics Inc

Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.

Attovia Therapeutics Inc is a publicly traded company under the ticker symbol ATTO on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.